Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (371-380 of 560) with videos related to

Pageof 56
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 11, 2005
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat modelA C Piscaglia, M A Zocco, C Di Campli, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumorsJ A Sparano, R I Fisher, G R Weiss, et al.
Journal of Clinical Pathology|August 9, 2012
Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspectiveUmberto Malapelle, Claudio Bellevicine, Maria Salatiello, et al.
Breast Cancer Research and Treatment|August 7, 2024
Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppressionAlaina J Kessler, Rima Patel, Emily Jane Gallagher, et al.
JAMA Oncology|June 17, 2021
Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical TrialBetina Yanez, Robert J Gray, Joseph A Sparano, et al.
Journal of Translational Medicine|May 11, 2023
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patientsDomenico Galati, Serena Zanotta, Mariaelena Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphomaJohn P Leonard, Brian K Link, Christos Emmanouilides, et al.
Cancer Investigation|September 26, 2014
Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancerKevin Kalinsky, Emerson A Lim, Eleni Andreopoulou, et al.
Nature Communications|October 28, 2025
Tissue localization of natural killer cells dictates surveillance of lung metastasisMarijne Vermeer, Colin Sparano, Nicolò Coianiz, et al.
Journal of the National Cancer Institute|May 19, 2021
Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast CancerOlga Kantor, Tari A King, Steven Shak, et al.
Pageof 56

Showing results (371-380 of 560) with videos related to

Sort By:
Pageof 56
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 11, 2005
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat modelA C Piscaglia, M A Zocco, C Di Campli, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumorsJ A Sparano, R I Fisher, G R Weiss, et al.
Journal of Clinical Pathology|August 9, 2012
Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspectiveUmberto Malapelle, Claudio Bellevicine, Maria Salatiello, et al.
Breast Cancer Research and Treatment|August 7, 2024
Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppressionAlaina J Kessler, Rima Patel, Emily Jane Gallagher, et al.
JAMA Oncology|June 17, 2021
Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical TrialBetina Yanez, Robert J Gray, Joseph A Sparano, et al.
Journal of Translational Medicine|May 11, 2023
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patientsDomenico Galati, Serena Zanotta, Mariaelena Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphomaJohn P Leonard, Brian K Link, Christos Emmanouilides, et al.
Cancer Investigation|September 26, 2014
Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancerKevin Kalinsky, Emerson A Lim, Eleni Andreopoulou, et al.
Nature Communications|October 28, 2025
Tissue localization of natural killer cells dictates surveillance of lung metastasisMarijne Vermeer, Colin Sparano, Nicolò Coianiz, et al.
Journal of the National Cancer Institute|May 19, 2021
Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast CancerOlga Kantor, Tari A King, Steven Shak, et al.
Pageof 56